Wells Fargo & Company X Biotech Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in X Biotech Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 11,701 shares of XBIT stock, worth $35,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,701

Previous 9,153 27.84%

Holding current value

$35,337

Previous $70,000 34.29%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$3.8 - $8.25 $9,682 - $21,021	2,548 Added 27.84%	11,701 $46,000
Q3 2024 Nov 13, 2024	BUY	$5.55 - $7.95 $5,683 - $8,140	1,024 Added 12.6%	9,153 $70,000
Q2 2024 Aug 13, 2024	BUY	$4.54 - $9.89 $36,201 - $78,862	7,974 Added 5144.52%	8,129 $41,000
Q1 2024 May 10, 2024	BUY	$4.03 - $8.13 $12 - $24	3 Added 1.97%	155 $1,000
Q4 2023 Feb 09, 2024	BUY	$3.56 - $4.65 $28 - $37	8 Added 5.56%	152 $0
Q3 2023 Nov 13, 2023	BUY	$4.02 - $5.81 $68 - $98	17 Added 13.39%	144 $0
Q2 2023 Aug 15, 2023	BUY	$3.06 - $6.38 $15 - $31	5 Added 4.1%	127 $0
Q1 2023 May 12, 2023	BUY	$3.22 - $4.72 $6 - $9	2 Added 1.67%	122 $0
Q4 2022 Feb 13, 2023	BUY	$3.03 - $3.79 $9 - $11	3 Added 2.56%	120 $0
Q3 2022 Nov 14, 2022	BUY	$3.58 - $5.88 $53 - $88	15 Added 14.71%	117 $0
Q2 2022 Aug 12, 2022	SELL	$5.13 - $9.2 $107,796 - $193,319	-21,013 Reduced 99.52%	102 $1,000
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $139,682 - $189,315	-16,167 Reduced 43.36%	21,115 $182,000
Q4 2021 Feb 14, 2022	SELL	$10.95 - $16.07 $1.21 Million - $1.77 Million	-110,165 Reduced 74.71%	37,282 $415,000
Q3 2021 Nov 15, 2021	SELL	$12.95 - $18.24 $816,329 - $1.15 Million	-63,037 Reduced 29.95%	147,447 $1.91 Million
Q2 2021 Aug 16, 2021	SELL	$15.83 - $17.84 $269,632 - $303,868	-17,033 Reduced 7.49%	210,484 $3.49 Million
Q1 2021 May 13, 2021	BUY	$15.92 - $20.3 $1.81 Million - $2.3 Million	113,382 Added 99.34%	227,517 $3.91 Million
Q4 2020 Feb 09, 2021	BUY	$15.65 - $19.92 $654,185 - $832,675	41,801 Added 57.79%	114,135 $1.79 Million
Q3 2020 Nov 05, 2020	BUY	$13.97 - $21.16 $200,301 - $303,392	14,338 Added 24.72%	72,334 $1.38 Million
Q2 2020 Aug 13, 2020	BUY	$10.39 - $16.07 $461,991 - $714,552	44,465 Added 328.62%	57,996 $795,000
Q1 2020 May 14, 2020	BUY	$8.89 - $24.94 $120,290 - $337,463	13,531 New	13,531 $144,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.7M

Call Options Held

200

Put Options Held

12.8K

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $91.9M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company X Biotech Inc. Transaction History